can i switch from tirzepatide to semaglutide Switching semaglutide: complete transition guide Switch from Tirzepatide to Semaglutide:

The Evidence Multiple large cardiovascular outcome trials have demonstrated GLP-1 medications reduce heart attacks, strokes, and cardiovascular death: SUSTAIN-6 (semaglutide): 26% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk

G.LavazzaA.et al (2012)

After four weeks of treatment, patients in the CT-996 arm of the trial saw a 7.3% drop in body weight, whereas placebo counterparts saw only 1.2% weight-loss

Can PlushCare perform preoperative evaluations on prospective bariatric surgical patients?No, we do not provide evaluations for bariatric surgery

This model helps patients develop lasting habits while on treatment, which supports long-term success whether medication continues or is eventually tapered